← Browse by Condition
Medical Condition

double hit lymphoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT05908409 Phase 1, Phase 2
Recruiting

A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies

Enrollment
37 pts
Location
Spain
Sponsor
IDP Discovery Pharma S.L.
View Trial →